WE CAN HELP
Book a FREE consultation  
For a free consultation or assistance, please call 020 7730 6666

Hair Loss Blog

Browse by Category

Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s Female Pattern Hair Loss Treatment Success Stories gallery.

Find out what this client had to say and see her regrowth results close up, or find out more about treating hereditary hair loss in women by clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Treatment information


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

New research into women’s risk of developing breast cancer has turned up some significant information, particularly for women of colour.

Findings from a seven-year study, published in the International Journal of Cancer, showed that regularly using permanent hair dye may raise a woman’s risk of developing breast cancer to around 60 per cent.

Furthermore, chemical hair treatments used to straighten the hair were also found to considerably raise women’s chances of getting breast cancer, with black women most harshly affected in each case.

Hair dyes, relaxers and Brazilian blow dry pose increased breast cancer risk

Relaxed hair coloured hair bleached hair dye afro hair straightened chemical straightener

A North Carolina-based team studied the association between hair products and breast cancer in 46,709 women. Each was aged between 35 and 74, and had a sister with breast cancer, but had no history of breast cancer themselves.

Through the use of questionnaires regarding hair product use over the 12 month period prior to enrolment, it was noted that 55 per cent of participants used hair dye when they started the trial.

At the follow up screenings, approximately 8.3 years after the study began, 2,794 cases of breast cancer were identified among those taking part.

Upon further investigation, researchers made the following associations:

  • an increased breast cancer risk of 45 per cent in black women who regularly use permanent hair dye;
  • an increased breast cancer risk of 7 per cent in white women who regularly use permanent hair dye;
  • risk of developing breast cancer rises with increased frequency of dye or straightener use;
  • an increased breast cancer risk of up to 60 per cent in black women who dye their hair at least every five to eight weeks;
  • chemical hair straightener (such as relaxers or Brazilian blow dry services) use linked to higher risks of developing breast cancer – particularly among black women whose use of such treatments was tallied at 75 per cent among participants, versus just 3 per cent of white women;
  • non-professional application of semi-permanent hair dye or chemical hair straightening products to another person linked to an increased risk of developing breast cancer.

In conclusion, the team stated, “We observed a higher breast cancer risk associated with any straightener use and personal use of permanent dye, especially among black women. These results suggest that chemicals in hair products may play a role in breast carcinogenesis”.

The Guardian published an interesting piece about how breast cancer often hits black women harder, with affected women of colour being 40 per cent more likely to die from the disease than white women in America – the country where this new research was carried out.

Not only is this due to various socioeconomic factors, including many African American women’s traditional ‘need’ to straighten their natural hair in order to conform to Western beauty standards – discrimination against Afro hair is known to be rife, and was only made illegal in some parts of America in late 2019 – but also due to the toxic chemicals numerous hair products aimed at black women have been found to contain.

Additional damage chemical hair treatments can cause

Whilst these figures make for sobering reading, there are a number of less physically impactful, but often emotionally draining adverse events connected to the use of chemical hair treatments.

Hair Cuticle Health - Damaged hair v healthy hair diagram - hair breakage

Use of chemical relaxers has been linked to endocrine disruption, as well as an increased risk of miscarriage for hairdressers who are regularly exposed to these products at close range.

Over-dyeing and over-bleaching can severely damage hair, causing breakage, where the weakened hair strands snap off. Relaxers, including keratin-based Brazilian blow drys, can also be responsible.

Harsh chemicals such as these, if the solution is too strong or they are left on for too long, may cause hair loss from a condition called Chemical Trauma. This is essentially burns to the scalp and, depending on how badly burned the follicles are, this can result in patches of permanent baldness in extreme cases.

Although the evidence is currently anecdotal, Belgravia often receives enquiries from people who have noticed thinning hair soon after having a Brazilian blow dry – a treatment designed to ensure a smoother, more longer-lasting blow out.

When it comes to hair straightening, whilst heat damage is also a consideration, occasional use of flat irons or a roller brush blow dry are preferable to chemical straightening. Just be careful to use a heat protector product first, to help disperse the heat more evenly, and not to pull too hard when using a brush, as repeated blow-drying which harshly pulls at the hair may cause Traction Alopecia in any hair type. For Afro textured hair, a chemical- and heat-free technique known as African Threading is a great alternative.

For those who still wish to use such hair products, the best advice is to consult a professional and experienced stylist who can properly mix and apply these for you. For those using home-use kits, it is crucial to always follow the instructions to the letter, and if you are in any doubt or have any queries regarding the application process, always contact the brand or retailer for answers first.

Perhaps the most important point in both cases, whether you are getting your hair done at a salon or doing it yourself, is to carry out a patch test at least 48 hours in advance. This is key even if you have used the same product before as intolerances can build up so you may react differently, even to the same product, at different times.


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s Male Hair Loss Treatment Success Stories gallery.

Find out what this client had to say and see his regrowth results close up, or find out more about treating Male Pattern Baldness by clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Treatment information


The Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

HairlossANSWERS - Click to Submit Your Query to Our Hair Loss Experts

Name: Gem

Question: My hair looks thin when it’s wet but then looks thicker again when it’s dry. I have noticed it feeling a little thinner recently, like I’m losing hair density in general, but I don’t see any specific signs of thinning so is this normal?

why does wet hair looks thinner than dry hair

Answer: Hi, Gem. Hair looks thinner when wet because the hair clumps together creating several partings, hence the scalp looks more visible.

This can also be the case when gel, wax or other hair products which ‘stick’ the hair together are used.

When hair is dry, it separates; this provides the scalp with more coverage.

The moisture from the water also weighs the hair down, giving wet hair the appearance of having less volume than dry hair, whether you have a hair loss condition or not.

However, the fact that you are noticing this hair thinning alongside a reduced hair density does suggest a form of hair loss. The fact that you mention not seeing any specific signs of hair loss indicates a generalised thinning.

If this thinning hair and drop in hair density – sometimes referred to as invisible hair loss – is mainly found along the top part of your scalp known as the vertex, which could mean in any, or all of the areas from crown to hairline and temples, this is most likely to be androgenetic alopecia. This is more commonly known as Male Pattern Baldness or Female Pattern Hair Loss.

This is an incredibly common hereditary condition and there are clinically-proven, MHRA-licensed and FDA-approved hair loss treatments available for this, as well as a number of additional hair growth supporting products.

Where there is a decreased hair volume all over the scalp, a diagnosis of temporary hairloss from Telogen Effluvium would be more likely, though if this were the case, you would have almost certainly also have noticed a period of intense hair fall. As you have not mentioned this, it seems more likely that genetic hair loss may be at play here.

We recommend having a professional consultation, either in-person or online to determine precisely which condition is present. That way, personalised hair loss solutions can be recommended, based on your condition, medical history, level and pattern of shedding, and age, if appropriate.


The Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s Women’s Hair Loss Treatment Success Stories gallery.

This client has two separate conditions – Diffuse Hair Loss and Female Pattern Hair Loss which are being treated simultaneously.

Find out what this client had to say and see her regrowth results close up, or find out more about treating hereditary Female Pattern Hair Loss and Diffuse Hair Lossby clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Female Pattern Hair Loss Treatment information

Diffuse Hair Loss Treatment Information


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Addpharma Inc, a South Korean drug research and development agency, has initiated clinical trials into low doses of the enlarged prostate medication, dutasteride, as a treatment for Male Pattern Baldness.

Dutasteride, which is also known by its GlaxoSmithKline brand name Avodart, is similar to the only currently MHRA-licensed and FDA-approved oral male hair loss treatment, finasteride 1mg, in that it inhibits the formation of dihydrotestosterone (DHT).

DHT is the testosterone-derivative which binds to receptors in sensitive follicles along the top of the scalp, anywhere from hairline to crown, in men – or women – with a genetic predisposition to androgenetic alopecia. This action gradually weakens the hair follicles; over time this slow destruction presents outwardly as the thinning hair and/or receding hairline we typically associate with hereditary hair loss.

Dutasteride and Male Pattern Baldness

By disabling DHT in adult males after puberty, once it is no longer of use to the body, these DHT-blockers have been shown to help men with Male Pattern Hair Loss maintain normal hair growth.

Reducing or stopping the process of follicular miniaturisation in this way, can help in preventing baldness. Continues below…

Diagram of Follicular Miniaturisation hair follicel shrinkage from genetic hair loss male pattern baldness
Diagram of Follicular Miniaturisation hair follicle shrinkage from genetic hair loss

Though both decrease the formation of DHT, the difference between dutasteride and finasteride is that, whilst finasteride acts upon one of the two types of DHT in the body, dutasteride acts on both.

As dutasteride is a more potent drug than finasteride and stays in the bloodstream for longer, the risk of adverse effects is higher, with side effects also potentially being more persistent.

At present only finasteride 1mg is permitted, DHT-inhibitor-wise, for prescription for this condition. Even then, in the UK and USA, it must only be given to medically suitable men aged 18 and over. The reason for this is largely to do with safety concerns relating to dutasteride.

Dutasteride is used as an authorised male hair loss treatment in a few countries, including Japan, and may be used in some instances as an ‘off-label’ or unofficial treatment under the strict guidance of a medical professional.

Although a cursory glance at any hairloss message board will reveal many men claiming to order dutasteride from internet sources – as with any prescription-only medication – this is highly inadvisable and can be extremely dangerous.

Avodart box dutasteride

Testing dutasteride for safety

This new Addparma trial aims to assess the pharmacokinetics and safety of a tablet known as ‘AD-208’ which contains 0.2mg of dutasteride, and Avodart soft capsules in 0.5mg dutasteride doses.

The clinical trial involves “healthy adult male volunteers”, all aged between 19 and 50 years. Interestingly, neither the inclusion criteria, nor the exclusion criteria for these participants mentions Male Pattern Baldness or any other form of hair loss. In fact, the specification of ‘healthy’ men suggests they are testing these drugs on men without genetic hair loss.

According to its clinical trial registration information, the study started recruiting on 3rd January 2020. Research will be carried out at Kyungpook National University Hospital in the Republic of Korea, and has an estimated completion date of March 2020.

As such, this appears to be a preliminary test, most likely as part of an information-gathering exercise before more targeted trials take place.

We will publish updates on this investigation as information becomes available; in the meantime, you can find out more about current options for treating men’s hair loss using clinically-proven medications and hair growth supporting products, on our dedicated Hair Loss Treatments page, or by having an in-person or online consultation with a dedicated specialist.


Belgravia Centre Hair Loss Clinic Hair Loss Specialist Free ConsultationThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s Male Hair Loss Treatment Success Stories gallery.

Find out what this client had to say and see his regrowth results close up, or find out more about treating Male Pattern Baldness by clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Treatment information


The Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

A substantial number of study findings were published in 2019 which linked the hair loss-causing autoimmune disorder Alopecia Areata (AA) to depression.

The highly visible nature of these hair loss conditions, which can cause anything from bald spots on the scalp to complete baldness from head to toe, was thought to contribute to the psychological and emotional difficulties of those affected.

In January 2019 it was also found that, not only is depression more common in people with Alopecia Areata, but having depression may significantly increase the risk of developing alopecia.

On 2nd January 2020, in Scottish research findings published in the British Journal of Dermatology, two specific molecules – type 17 and type 2 cytokines – were shown to exhibit positive correlations with both Alopecia Areata and depression.

Dysregulation in systemic type 17 and type 2 cytokines

These researchers wanted to explore the link between mental health and Alopecia Areata, reasoning that, “Unfortunately, 60 per cent of people with AA will also develop depression, anxiety or a related condition.”

Their primary aims were to find out whether people with Alopecia Areata had different levels of molecules that had been produced by the immune system in their blood. Previous research into other autoimmune diseases, such as rheumatoid arthritis, has made connections between molecules produced by immune cells and depression.

When comparing their clinical results to those of people without Alopecia Areata, the team discovered “increased levels of multiple molecules that are produced by activated immune cells” in the Alopecia Areata group.

Complex questionnaires were then used to establish depression scores for both the participants with Alopecia Areata, and those without. When using both sets of data to establish if there was a connection between these molecules and the depression some of the AA participants had, two specific molecules stood out. These were systemic type 17 and type 2 cytokines which were notably elevated in those with AA and these levels being associated with how depressed the individual was.

As such, the team concluded: “Alopecia Areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity.”

Research part-funded by Alopecia UK

Their studies were funded by a PhD studentship grant from Medical Research Scotland, part funded by the pharmaceutical company AstraZeneca, with additional funding from the hair loss charity, Alopecia UK.

Alopecia UK is the biggest charity in the country that is dedicated to supporting those with medical hairloss. In addition to providing online resources, running local peer support groups and running many events where people who are affected by any form of Alopecia Areata – or their friends and family – can get together, it also funds research into the condition.

It is hoped this new information will help to further the medical community’s understanding of autoimmune alopecia and its relationship with depression and other mental health problems, and be of use to those developing new Alopecia Areata treatments.


The Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories


Belgravia Centre Hair Loss Treatment Before and After Results - New Success Story

A new entry has just been added to Belgravia’s women’s hair loss treatment Success Stories gallery.

This client has three separate conditions – Female Pattern Hair Loss, Traction Alopeciaand Follicular Degeneration Syndrome which are being treated simultaneously, thanks to a personalised treatment plan available from Belgravia, as devised by her dedicated hair loss specialist.

Find out what she had to say about her regrowth results so far and see them close up, or find out more about treating Female Pattern Hair Loss, Traction Alopeciaor Follicular Degeneration Syndrome by clicking the buttons below…

(Results may vary and are not guaranteed)

VIEW SUCCESS STORY

Traction Alopecia Treatment

Female Pattern Hair Loss Treatment

Follicular Degeneration Syndrome Treatment


The Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

HairlossANSWERS - Click to Submit Your Query to Our Hair Loss Experts

Name: Drew

Question: Do you still get seasonal shedding on hair loss treatment? I’m using fin + minox for MPB and wanted to know if the hair fall I’m noticing at the moment is normal or if it means my treatment isn’t working.

Answer: Hi, Drew. Yes, you can still experience seasonal shedding if you’re using hair loss treatment.

It still happens even when using minoxidil as it is a normal part of the hair growth cycle.

seasonal hair loss extra shedding autumn fall male pattern baldness

For Belgravia patients who’ve been with us for many years, we can often see its effects at the same time every year. However, the seasonal shedding may present differently in each person.

Although many people notice shedding in autumn, others may find they experience this hair fall in a different season. It is just a normal function of the hair growth cycle and nothing to be concerned about.

Once a year we might have a slightly higher percentage of hair follicles being in the telogen phase than usual, which then leads to slightly more hair loss than the usual daily amount.

It is an interesting area of study and certainly does seem to have some seasonality to it, as confirmed by research into Google search trends from 2004 to 2016. Analysis of this data was carried out by a team at John Hopkins Medicine in the USA and published in the British Journal of Dermatology in 2017.

The researchers concluded: “Maximal proportions of telogen hair have been found to occur in the summer, whereas lowest rates of telogen hairs occur in the winter. Additionally, a recent study demonstrated that maximal hair shedding occurs in August and September, and that the percentage of hairs in the anagen phase peaks at the beginning of spring.

Further studies evaluating the seasonality and hair loss relationship, as well as exploring the effect of other potential mediating factors, are needed.

Additionally, according to previous research findings from February 1991, which touched on body hair as well and was also published in the British Journal of Dermatology, “Various parameters of hair growth were determined every 28 days for 18 months in 14 healthy Caucasian men aged 18–39 with indoor occupations in Sheffield, U. K. (latitude 53.4°N). In the scalp the proportion of follicles in anagen reached a single peak of over 90% in March, and fell steadily to a trough in September.

Hair Growth Cycle Diagram

The number of shed hairs reached a peak around August/September, when least follicles were in anagen. At this time the average loss of hairs was about 60 per day, more than double that during the preceding winter.

The rate of growth of the beard was lowest in January and February and increased steadily from March to July to reach a peak about 60% above the winter level. The rate of growth of thigh hair showed a similar pattern though with less pronounced differences. No seasonal fluctuations in finger ‐ or toenail growth were detected.”

As you can see, this is a regular occurrence and nothing to be startled by, but if you have noticed increased hair fall over a period of more than one month, or if you have developed sudden hair loss, especially if it is leaving behind bald spots, it is best to consult a professional.

A dedicated hair loss specialist will be able to tell the difference between temporary seasonal shedding and different hair loss conditions, and can also provide you with personalised advice and recommendations for appropriate hair loss solutions and hair growth supporting products, where relevant.


Circ - Belgravia Centre Hair Loss Clinics LondonThe Belgravia Centre

The Belgravia Centre is an organisation specialising in hair growth and hair loss prevention with two clinics and in-house pharmacies in Central London, UK. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the world. View our Hair Loss Success Stories, which includes the world’s largest gallery of hair growth comparison photos and demonstrates the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time to arrange a free consultation.

Related Stories